Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Freenome, Inc. - Common stock (NQ:FRNM)

10.95 -0.62 (-5.32%)
Delayed Quote Updated: 1:36 PM EST, Nov 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Freenome, Inc. - Common stock

News headline image
Freenome Reports Third Quarter 2026 Financial Results
From Freenome, LLC
Via GlobeNewswire
News headline image
Freenome Expands Personalized Cancer Detection Portfolio, Launching SimpleScreen™ Lung Test With FDA-Approved SimpleScreen CRC Option
From Freenome, LLC
Via GlobeNewswire
News headline image
Freenome to Report Third Quarter 2026 Financial Results on November 10, 2026
From Freenome, LLC
Via GlobeNewswire
News headline image
Freenome to Present New Validation Data for Next-Generation CRC Screening Test in Late-Breaking Oral Presentation at ACG 2026
From Freenome, LLC
Via GlobeNewswire
News headline image
FDA Grants Breakthrough Device Designation to Freenome’s Blood-Based SimpleScreen™ Lung Cancer Screening Test
Investigational AI-powered multiomic test is being developed for adults ages 50-80 at high risk who are not currently participating in guideline-recommended lung cancer screening 
From Freenome, Inc.
Via GlobeNewswire
News headline image
FDA Approves Freenome’s SimpleScreen™ CRC Blood-Based Screening Test; Abbott to Commercialize in the U.S.
From Freenome, Inc.
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.